SE0202693D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE0202693D0
SE0202693D0 SE0202693A SE0202693A SE0202693D0 SE 0202693 D0 SE0202693 D0 SE 0202693D0 SE 0202693 A SE0202693 A SE 0202693A SE 0202693 A SE0202693 A SE 0202693A SE 0202693 D0 SE0202693 D0 SE 0202693D0
Authority
SE
Sweden
Prior art keywords
compounds
pharmaceutical compositions
therapy
preparing
processes
Prior art date
Application number
SE0202693A
Other languages
Swedish (sv)
Inventor
Dave Chapman
Anders Eriksson
Anna Kristoffersson
Kristina Stenvall
Igor Shamovsky
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0202693A priority Critical patent/SE0202693D0/en
Publication of SE0202693D0 publication Critical patent/SE0202693D0/en
Priority to PCT/SE2003/001407 priority patent/WO2004024718A1/en
Priority to AU2003258942A priority patent/AU2003258942A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention provides compounds of formula in which R<1>, G<1> and G<2> have the meanings defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.
SE0202693A 2002-09-11 2002-09-11 Compounds SE0202693D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0202693A SE0202693D0 (en) 2002-09-11 2002-09-11 Compounds
PCT/SE2003/001407 WO2004024718A1 (en) 2002-09-11 2003-09-10 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors
AU2003258942A AU2003258942A1 (en) 2002-09-11 2003-09-10 Imidazolidinedione-derivatives and their use as metalloproteinase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0202693A SE0202693D0 (en) 2002-09-11 2002-09-11 Compounds

Publications (1)

Publication Number Publication Date
SE0202693D0 true SE0202693D0 (en) 2002-09-11

Family

ID=20288963

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0202693A SE0202693D0 (en) 2002-09-11 2002-09-11 Compounds

Country Status (3)

Country Link
AU (1) AU2003258942A1 (en)
SE (1) SE0202693D0 (en)
WO (1) WO2004024718A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0100902D0 (en) 2001-03-15 2001-03-15 Astrazeneca Ab Compounds
SE0103710D0 (en) 2001-11-07 2001-11-07 Astrazeneca Ab Compounds
SE0202539D0 (en) 2002-08-27 2002-08-27 Astrazeneca Ab Compounds
SE0401763D0 (en) * 2004-07-05 2004-07-05 Astrazeneca Ab Compounds
TW200626142A (en) * 2004-09-21 2006-08-01 Glaxo Group Ltd Chemical compounds
SE0403085D0 (en) * 2004-12-17 2004-12-17 Astrazeneca Ab Novel componds
SE0403086D0 (en) * 2004-12-17 2004-12-17 Astrazeneca Ab Compounds
TW200740769A (en) 2006-03-16 2007-11-01 Astrazeneca Ab Novel process
EA200970349A1 (en) 2006-10-05 2010-02-26 Янссен Фармацевтика Н.В. METHOD PROTECT INHIBITORS OF HETEROCYCLIC ORIGIN
WO2009007747A2 (en) * 2007-07-11 2009-01-15 Astrazeneca Ab Hydantoin derivatives used as mmp12 inhibitors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1191024A1 (en) * 2000-09-22 2002-03-27 Harald Tschesche Thiadiazines and their use as inhibitors of metalloproteinases
WO2002074750A1 (en) * 2001-03-15 2002-09-26 Astrazeneca Ab Metalloproteinase inhibitors
SE0100902D0 (en) * 2001-03-15 2001-03-15 Astrazeneca Ab Compounds

Also Published As

Publication number Publication date
WO2004024718A1 (en) 2004-03-25
AU2003258942A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
SE0300480D0 (en) Novel compounds
SE0104140D0 (en) Novel Compounds
SE0200920D0 (en) Novel compounds
SE0202539D0 (en) Compounds
SE0103836D0 (en) Novel compounds
ATE316083T1 (en) ADAMANTANDE DERIVATIVES
SE0301700D0 (en) Novel compounds
IS6658A (en) New compounds
SE0302811D0 (en) Novel compounds
HK1048990A1 (en) Novel compounds.
MY128924A (en) Novel compounds
TW200613243A (en) Novel compounds
DE602004021472D1 (en) Pyrimiidinverbindungen
SE0302139D0 (en) Novel compounds
SE9901875D0 (en) Novel compounds
AU2003228770A8 (en) Substituted pyrazolopyrimidines
SE0302192D0 (en) Novel compounds
TW200604197A (en) New compounds
SE0401762D0 (en) Novel compounds
TW200639156A (en) New compounds
SE0402925D0 (en) Novel Compounds
SE0101038D0 (en) Novel compounds
GB0104050D0 (en) Chemical compounds
GB0120461D0 (en) Novel compounds
SE0401763D0 (en) Compounds